Is heterogeneity in the effects of statins on infection outcomes across clinical studies due to bias?

Koen B. Pouwels; Eelko Hak

doi:10.1128/AAC.01839-16

Is heterogeneity in the effects of statins on infection outcomes across clinical studies due to bias?

Koen B. Pouwels^*
, Eelko Hak

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	7002-7003
Number of pages	2
Journal	Antimicrobial Agents and Chemotherapy
Volume	60
Issue number	11
DOIs	https://doi.org/10.1128/AAC.01839-16
Publication status	Published - 1 Nov 2016

Bibliographical note

Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1128/AAC.01839-16

Cite this

@article{5426b4c2be9649938ce4292fcebcc78b,

title = "Is heterogeneity in the effects of statins on infection outcomes across clinical studies due to bias?",

author = "Pouwels, \{Koen B.\} and Eelko Hak",

year = "2016",

month = nov,

day = "1",

doi = "10.1128/AAC.01839-16",

language = "English",

volume = "60",

pages = "7002--7003",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",